According to a Reuters report, Johnson & Johnson has announced that they are aiming to begin in September a late-stage study of their experimental vaccine for the novel coronavirus, as researchers work at break-neck speed to develop a shot to combat the fast-spreading pathogen.
Why is it important?The New Brunswick, New Jersey-based healthcare conglomerate, which expects to start human trials of its vaccine this month, lags other companies that also are developing coronavirus vaccines, with...
https://mfame.guru/johnson-johnson-to-begin-phase-3-covid19-vaccine-trials/